Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.
Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser
Mohammad Reza Sheikhi, Aliabbas Zia, Seyed Jalal Zargar
Backgorund: Many studies have reported the anticancer effects of cucurbitacins. However, related molecular events need to be described. The current study aims at evaluating the impact of cucurbitacins D, E, and I on death and survival pthways in colorectal cancer (CRC).
Methods: Cell viability was determined by MTT assay in both SW-480 and HT-29 (only cucurbitacin-E). Total RNA was extracted, and the expression of mRNA was quantified by real-time RT-PCR analysis.
Results: The MTT results for SW-480 revealed that cucurbitacins E and I had almost similar potency in different doses, but cucurbitacin-D only had up to almost 50% lethality as a function of dose. Cucurbitacin-E reached IC50 in a very lower dosage at 6 micromolar in HT-29. The expression levels of BAX mRNA were significantly decreased or remained almost unaltered (HT-29) and that of BCL-2 mRNA witnessed a considerable increase (p˂0.05), which is a non-canonical paradigm. What is more, while the expression levels of p53 and AIF mRNA was increased in all treatments of cucurbitacins in SW-480, they were suppressed in HT-29 cells treated with cucurbitacin-E. Caspase-3 expression increased in both colon cell lines. According to expression patern, only cucurbitacin-I had the possibility of suppressing the AKT-mTOR pathway. While autophagy genes were increased in cucurbitacins, cucurbitacin-I decreased the ATG5 expression level.
Conclusion: We noticed that cucurbitacins have the potential to reveal more about both non-canonical interactions of death pathway and BAX/BAk independent apoptosis. These results indicate that cucurbitacins might contribute to BAX/BCL-2-independent cell death in CRC cells.